The QualityStocks Daily Tuesday, September 1st, 2020

Today's Top 3 Investment Newsletters

MarketClub Analysis (JNCE) +55.58%

InvestorPlace (ZM) +40.78%

SmallCapRelations (IONKF) +38.69%

The QualityStocks Daily Stock List

Acacia Pharma Group plc (ACPGF)

Investors Hangout, The Hot Penny Stocks, Investing.com, Stocks Café, Wallet Investor, OTC Markets, Speculating Stocks, Investor Point, Simply Wall St, Macroaxis, Stockhouse, Current Charts, Business Insider, and InvestorsHub reported beforehand on Acacia Pharma Group plc (ACPGF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

A commercial stage biopharmaceutical company, Acacia Pharma Group plc centers on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments including surgery, invasive procedures, or chemotherapy. It has developed a late-stage pipeline of hospital nausea and vomiting product candidates based on repurposing existing drugs in new therapeutic indications. Its product candidates are differentiated from the original marketed drug by using a different delivery method and/or dose that is suitable for its new medical use.

Acacia Pharma Group is headquartered in Cambridge, the United Kingdom (UK). The Company’s U.S. operations are centered in Indianapolis, Indiana. Acacia Pharma lists on the OTC Markets.

The Group has discovered two product candidates based on the same active ingredient, amisulpride. BARHEMSYS® (formerly APD421) is an intravenous formulation of amisulpride, a selective dopamine antagonist that has completed Phase 3 clinical development for the prophylaxis and treatment of post-operative nausea & vomiting (PONV), alone and in combination with other antiemetics.

APD403 is based on the selective dopamine antagonist amisulpride, the same active ingredient as in BARHEMSYS®. It is undergoing development as an intravenous injection for cancer patients to be administered immediately before they receive chemotherapy to prevent acute chemotherapy-induced nausea & vomiting (CINV), and as an oral tablet to prevent delayed CINV.

In January 2020, Acacia Pharma Group announced that it entered into a strategic in-licensing transaction with Cosmo Pharmaceuticals N.V. (SIX: COPN). The transaction grants to the Group exclusive U.S. commercialization rights to BYFAVO™ (remimazolam). It was made alongside an equity investment and debt facility by Cosmo Pharmaceuticals to finance the marketing efforts of BARHEMSYS® and BYFAVO™.

BYFAVO™ is an ultra-short-acting and reversible intravenous sedative/anaesthetic. It has demonstrated efficacy and safety in an extensive clinical trial programme involving roughly 2,400 volunteers and patients.

In August, Acacia Pharma Group announced that BARHEMSYS® (amisulpride injection) was launched and is presently commercially available in the United States for order and delivery to customers via major wholesalers and specialty distributors. BARHEMSYS was approved by the US Food and Drug Administration (FDA) for the treatment and prevention of postoperative nausea & vomiting (PONV) on February 26, 2020.

Mr. Mike Bolinder, Acacia Pharma Group Chief Executive Officer, said, “BARHEMSYS is the first and only antiemetic to be approved for the rescue treatment of PONV in patients who have failed prior prophylaxis with an agent of a different class using current standard of care and we estimate there are approximately 16 million such surgical patients each year in the US that go on to suffer from PONV despite receiving prophylaxis. We believe there will be strong demand for BARHEMSYS as US healthcare institutions seek to address surgical backlogs created by the coronavirus crisis and are very happy to make this new therapy available in the US.”

Acacia Pharma Group plc (ACPGF), closed Tuesday's trading session at $2.45, even for the day, on 3,000 volume. The stock's 52-week low/high is $2.45000004/$5.00.

Charlie's Holdings, Inc. (CHUC)

Stock Analysis, StocksCafe, OTC Markets, Zacks, Stockopedia, Barchart, PR Newswire, InvestorsHub, Nasdaq, Ask Finny, Simply Wall St, Investors Observer, Seeking Alpha, Street Insider, Finbox, last10k, Accesswire, Investors Hangout, TipRanks, Wallet Investor, Stockwatch, Business Insider, and MacroTrends reported beforehand on Charlie's Holdings, Inc. (CHUC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Charlie's Holdings, Inc. is an industry leader in the premium, nicotine-only, e-cigarette space and the hemp-derived, CBD (cannabidiol) wellness space. The Company operates via its subsidiary companies Charlie's Chalk Dust, LLC, and Don Polly, LLC. Its primary international markets include the United Kingdom (UK), Italy, Spain, Belgium, Australia, New Zealand, and Canada. The Company previously went by the name True Drinks Holdings, Inc. Charlie's Holdings is based in Costa Mesa, California and lists on the OTC Markets.

Charlie's Chalk Dust produces high quality vapor products currently distributed in more than 90 countries. Charlie's Chalk Dust has developed a wide-ranging portfolio of brand styles, flavor profiles, as well as innovative product formats. Don Polly, LLC was launched in June of 2019. This subsidiary formulates unique hemp-derived CBD wellness products. Don Polly's premier CBD products derive from single-strain-sourced hemp extract and high purity CBD isolate crystals.

Key highlights for Q1 2020 for Charlie's Holdings include partnering with Blackbriar Regulatory Services to direct submission of Premarket Tobacco Product Application (PMTA). Charlie’s Holdings plan is to concentrate on increasing the sales of its CBD related products. This includes topicals, tinctures, and vaping liquids. It has started to focus on numerous vertical markets for the sale of its isolate, full, and broad-spectrum products. These vertical markets include, but are not limited to, the medical and wellness markets.

Additionally, the Company sees a significant opportunity for sales growth in global markets for nicotine e-liquids. At present, about 25 percent of its e-liquid product sales come from the international market. Also, Charlie's Holdings believes that the nicotine based flavored vaping products will continue to be a major growth opportunity, once all the rightful regulatory changes have been made. The Company will continue with its plan to obtain marketing authorization for certain of its products through the submission of a PMTA, which is due this month.

Last month, Charlie's Holdings announced its financial results for Q2 ended June 30, 2020. Important highlights for Q2 2020 include increased sales mix to distributors, and increased participation from distributors and retailers in volume incentive programs. Important highlights also include added margin from direct-to-consumer e-commerce sales of CBD products, as well as stabilized manufacturing costs.

Revenue for the three months ended June 30, 2020 was $4,163,000. This represents a decrease of $2,656,000, or 39 percent, versus $6,819,000 for the three months ended June 30, 2019. The decrease was because of a $2,064,000 decrease in the Company’s nicotine-based product sales and a $571,000 decrease in sales of its CBD wellness products.

Mr. Brandon Stump, Chief Executive Officer of Charlie's Holdings, stated, "While we continue to experience industry headwinds from the nationwide vaping concerns and the uncertainty brought on from the global COVID-19 pandemic, we have taken the necessary steps to stabilize our manufacturing costs and reduce our operating expenses."

Charlie's Holdings, Inc. (CHUC), closed Tuesday's trading session at $0.0028, up 3.7037%, on 946,354 volume with 15 trades. The average volume for the last 3 months is 1,563,816 and the stock's 52-week low/high is $0.001099999/$0.025.

Jushi Holdings, Inc. (JUSHF)

NetworkNewsWire, WeedStreet420, Penny Stock Hub, New Cannabis Ventures, Market Wire News, InvestorX, OTC Markets, Barchart, Street Insider, Wallmine, Business Insider, OTC.Watch, Stockhouse, PR Newswire, NIC Investors, Cannabis News Wire, Baystreet.ca, BioSpace, Dividend Investor, Highwater Financial, Stockwatch, Energy and Capital, CannabisFN, Investing News, Stock Digest, Cannabis Daily, Corporate Knights, Green Market Report, Wallet Investor, and One News Page reported previously on Jushi Holdings, Inc. (JUSHF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Jushi Holdings, Inc. is an internationally-focused, multi-state cannabis and hemp operator. It focuses in the United States on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed workouts, and competitive applications. Established in 2018, Jushi Holdings is based in Boca Raton, Florida. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Jushi’s mission is to create an integrated global community of wellness, mindfulness, and connections via superior quality cannabis and hemp-derived products. The Company’s brands include Beyond/Hello, Nira, The Lab, and The Bank. Beyond/Hello is a brand of cannabis dispensaries.

Nira is a new line of hemp-based CBD (cannabidiol) products. They are physician-formulated and produced with full-spectrum hemp. Nira products are developed under the guidance of Dr. Laszlo Mechtler, MD, FAAN, FASN, FEAN, Professor of Neurology Oncology.

The Lab infused production facility has been in operation since 2010. Currently, the Lab is producing greater than one million grams of concentrate across 70-plus product formulations in a calendar year. The Bank genetics has been producing first-rate cannabis seeds and flower for the past decade.

Jushi Holdings has acquired 80 percent of the economic and voting interests in Agape Total Health Care, Inc., a Pennsylvania Dispensary Permittee. Jushi acquired a majority interest in Agape, who will open three retail locations: one in the Philadelphia region, one in Reading, and one in Pottsville.

Recently, Jushi Holdings announced that it received approval from the Pennsylvania Department of Health to open its eighth BEYOND/HELLO™ medical marijuana dispensary in the Commonwealth of Pennsylvania in partnership with Agape Total Health Care (BEYOND/HELLO™ Reading), and its 10th BEYOND /HELLO™ location nationally. BEYOND/HELLO™ Reading began serving patients and caregivers on Wednesday, July 15, 2020.

Last month, Jushi Holdings announced the closing of the earlier announced agreement to acquire 100 percent of the equity of Pennsylvania Medical Solutions, LLC, a Pennsylvania grower-processor (PAMS) previously owned by a subsidiary of Vireo Health International, Inc. (CSE: VREO) (OTCQX: VREOF). Through the completion of the Acquisition, Jushi Holdings adds PAMS and its 90,000 sq. ft. cannabis cultivation and processing facility.

For Q2 2020, Jushi Holdings reported that Total Revenue increased 73 percent sequentially to $14.9 million. The Company realized Gross Profit of $7.5 million. This represents an increase of 80 percent sequentially. Jushi’s Net Loss for Q2 was $9.3 million.

Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) (Loss) was $(1.2) million. This is a $4.8 million improvement versus Q1 of 2020. Jushi had $50.8 million of Cash and Securities on the balance sheet as of June 30, 2020. The Company had an Annualized Revenue Run-Rate for July 2020 of about $89 million, an approximate 80 percent increase over the March Annualized Run-Rate.

Jushi Holdings, Inc. (JUSHF), closed Tuesday's trading session at $2.17, up 0.462963%, on 195,793 volume with 489 trades. The average volume for the last 3 months is 94,132 and the stock's 52-week low/high is $0.25999999/$2.21000003.

NewAge, Inc. (NBEV)

Stocktwits, Stocklight, MacroTrends, Barchart, Stockhouse, Invest Chronicle, Investing.com, Morningstar, YCharts, Finviz, ShareInvestor.com, TMXmoney, Investors Observer, Stock of the Week, Stocknews, GlobeNewswire, Stockopedia, docoh, GuruFocus, ETF.com, Nasdaq, InvestorsHub, Seeking Alpha, Market Screener, Market Chameleon, Weedstreet420, Insider Tracking, MarketBeat, and MarketWatch reported earlier on NewAge, Inc. (NBEV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NewAge, Inc. is healthy and organic products company with a current presence in greater than 60 countries. Its commitment is to inspiring and educating consumers to “Live Healthy.” The Company is an omni-channel distribution enterprise with access to traditional retail, e-commerce, direct-to-consumer, as well as medical channels. Established in 2010, NewAge has its corporate headquarters in Denver, Colorado. The Company lists on the NasdaqGS.

In June of 2019, NewAge merged with Brands Within Reach, LLC (BWR) to expand its retail footprint and product portfolio. In February 2020, NewAge launched Noni+CBD shots in Japan, as one of the first major companies to gain approval from the Japanese Ministry of Health. This past March, NewAge launched TeMana Shape, the first product specifically formulated to support intermittent fasting, into a number of key markets globally.

NewAge markets a portfolio of better-for-you products. These includes the brands Tahitian Noni, the above-mentioned TeMana, Nestea, Volvic, Illy Coffee, Evian, Búcha Live Kombucha, ‘Nhanced and others.

In late July 2020, NewAge announced that it changed its name to NewAge, Inc. from New Age Beverages Corporation to reflect the strategic priorities of the business and to be representative of the considerable opportunities it sees in the broader consumer products goods arena. This change follows the recent announcement to combine with ARIIX and four additional e-commerce and direct selling companies. This will create an international organization with estimated pro forma revenues in excess of $500 million across greater than 75 countries.

In August, NewAge announced financial results for the quarter ended June 30, 2020 with Net Revenue reaching $62.6 million. This does not include Revenues from the Company’s recently announced combination with ARIIX and four other e-commerce, direct selling companies that is expected to more than double the size of the Company, and substantially improve the combined entity’s profitability. The expectation is that the pending merger will close during Q3 of this year.

Mr. Brent Willis, Chief Executive Officer of NewAge, said, “We are pleased with how the business is holding up in the current business environment, especially compared to most peer group companies. Despite our Japan and China markets being locked down because of the pandemic for much of the quarter, we are seeing good organic growth in North America, Latin America, Western Europe and recovery in certain Asia Pacific markets as they began to reopen.”

NewAge, Inc. (NBEV), closed Tuesday's trading session at $2.13, off by 1.8433%, on 1,777,527 volume with 5,337 trades. The average volume for the last 3 months is 3,153,032 and the stock's 52-week low/high is $0.981000006/$3.58999991.

Surge Components, Inc. (SPRS)

OTC Adventures, Zacks, FairlyValued, Morningstar, MarketBeat, Business Insider, Webull, Barchart, Businesswire, Stockhouse, GuruFocus, MarketWatch, Seeking Alpha, Stockopedia, Wallmine, Insider Tracking, CSI Market, Nasdaq, Investing.com, ADVFN.com, Wallet Investor, last10k, TipRanks, GlobeNewswire, Canadian Insider, MacroTrends, Market Screener, BDC Network, Proactive Investors, Finbox, and Emerging Growth reported earlier on Surge Components, Inc. (SPRS), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Surge Components, Inc. is a foremost supplier of capacitors, discrete semi-conductors, switches, and audible/sounding devices. The Company’s monthly production capacity is amongst the largest for these products, and Surge’s products are AECQ compliant for automotive applications. Surge Components provides all of its products RoHS and Pb-Free (Lead-Free). Surge sells its products to original equipment manufacturers (OEMs) and distributors via independent sales representatives or organizations in the U.S., Canada, China and other Asian countries, South America, and Europe. Established in 1981, Surge Components has its corporate headquarters in Deer Park, New York.

The Company offers capacitors, which are electrical energy storage devices; and discrete components, including semiconductor rectifiers, transistors, diodes, and circuit protection devices. In addition, Surge provides audible components. These include audible transducers, buzzers, speakers, microphones, resonators, alarms, chimes, filters, and discriminators. The Company also offers fuses, printed circuit boards, and switches.

Surge Components’ products are used in the electronic circuitry of diverse products. These include automobiles, telecomm, audio, cellular telephones, computers, consumer electronics, garage door openers, household appliances, power supplies, and security equipment.

Surge Components is among the top three international SCR and TRIAC suppliers. The Company has one of the most sophisticated wafer fab production capabilities in the world. Surge offers a line of switches for automotive applications and more. This lineup includes DIP, LED, as well as TACT styles.

New products from Surge Components include Surface Mount Glass Passivated Standard Rectifiers. New products additionally include new TACT switches. These include STCK-Waterproof (3.9 x 2.9 x 1.6); ST7B Low Profile SMT (7.5 x 7.0 x 0.6); and STAH Waterproof SMT (4.2 x 3.2 x 2.5).

The Company continues to expand its footprint globally. In South America, Surge continues to have success with its sales representative Tradecomp to increase its presence in Brazil. Furthermore, Surge has seen a consistent expansion in Revenue with its local distribution partners Avnet and Future Electronics throughout Brazil. In Asia, Surge continues to see more business opportunities converting into Revenue as the Surge brand continues to be recognized as a preferred line among customers on that continent.

Surge Components, Inc. (SPRS), closed Tuesday's trading session at $1.30, up 4.00%, on 1,500 volume with 3 trades. The average volume for the last 3 months is 1,441 and the stock's 52-week low/high is $1.10000002/$3.3499999.

Texas Mineral Resources Corp. (TMRC)

MarketWatch, OTC Markets, Nasdaq, Junior Mining Network, OilandGas360, Electric Energy Online, Stockwatch, Stockhouse, PR Newswire, Business Wire, OTC Dynamics, GlobeNewswire, Seeking Alpha, InvestorsHub, GuruFocus, YCharts, Barchart, MarketBeat, CoalZoom.com, NewMediaWire, Investing News, Morningstar, and Proactive Investors reported earlier on Texas Mineral Resources Corp. (TMRC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

An exploration company, Texas Mineral Resources Corp. (TMRC) is targeting the heavy rare earths, technology metals, and an array of industrial minerals. Its focus is to develop and commercialize its Round Top heavy rare earth, technology metals, and industrial minerals project situated in Hudspeth County, Texas. The OTCQB-listed Company previously went by the name Texas Rare Earth Resources Corp. It changed its name to Texas Mineral Resources Corp. in March of 2016. Incorporated in 1970, Texas Mineral Resources has its head office in Sierra Blanca, Texas.

Fundamentally, the Company believes it is crucial to re-establish the USA as the leader in technology, production, and refining of the strategically vital heavy rare earth elements. Its intention is to be the secure supplier of these elements that are the foundation of the United States’ defense and technological infrastructure. Texas Mineral Resources also plans on developing alternative sources of strategic minerals via the processing of coal waste and other related materials.

The Company’s flagship Round Top project is about 85 miles southeast of El Paso, Texas. Texas Mineral Resources holds 19-year renewable leases from the State of Texas on 950 acres covering Round Top and additional prospecting permits on adjacent areas encompassing an additional 9,345 acres. Round Top has ease of access to infrastructure (Electricity, Highway, Natural Gas, Rail, Water). It is positioned entirely on State Land (No BLM, No Forest Service).

Round Top is a large, Porphyry-Style REE Deposit (Massive Tonnage/Economies of Scale, Rich in CREE/HREE). Moreover, it has favorable mineralization (Yttrofluorite & Yttrocerite, Evenly Disseminated, Minimal Stripping Required).

This past July, USA Rare Earth, LLC, the funding and development partner of the Round Top Heavy Rare Earth and Critical Minerals Project in West Texas together with Texas Mineral Resources, announced its commitment to power operations at its Round Top Heavy Rare Earth & Critical Mineral Project in Hudspeth County, West Texas with 100 percent renewable energy. USA Rare Earth estimates it will require roughly 15 MW to support mining and processing, which it estimates will require a solar farm of around 45 acres.

Texas Mineral Resources Corp. (TMRC), closed Tuesday's trading session at $1.45, off by 7.6433%, on 199,244 volume with 375 trades. The average volume for the last 3 months is 421,590 and the stock's 52-week low/high is $0.215000003/$2.65000009.

The Tinley Beverage Company, Inc. (TNYBF)

NetworkNewsWire, TipRanks, Wall Street Reporter, Stockhouse, Beverage Start Up News, Wallet Investor, Street Insider, Pot Stock News, InvestorsHub, Small Cap Power, GlobeNewswire, Stockwatch, PR Newswire, MMJ Reporter, The CSE, Morningstar, Ceo.ca, Nasdaq, GuruFocus, Proactive Investors, TMXmoney, Accesswire, OTC Markets, Cannabis Daily, Seeking Alpha, MarketWatch, Marijuana Stock Review, Invest.com.com, Market Screener, NIC Investors, Daily Marijuana Observer, and TradingView reported previously on The Tinley Beverage Company, Inc. (TNYBF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

The Tinley Beverage Company, Inc. created the Tinley™ Tonics and Tinley™ ‘27 line of cannabis beverages. Non-Alcoholic Tinley™ Tonics and Tinley™ ’27 products are lower in sugar and calories than their beverage alcohol counterparts. Additionally, Company is building a 20,000 square foot cannabis beverage manufacturing and distribution facility in Long Beach, California. The Tinley Beverage Company was created with a mission to help consumers enjoy cannabis in familiar, classic beverages, Micro-Dosed to perfection. The Tinley Beverage Company is based in Santa Monica, California. The Company lists on the OTC Markets Group’s OTCQX (OTCQX Member since March 2018).

Tinley Beverage Company’s dedication is to excellence in formulation, sourcing, production, and distribution. The Company says that it has found the finest, fast-onset cannabis distillate from Northern California. It crafts it with premium essences of spirits and liqueurs, and also terpenes for a full-flower effect.

The Company’s multi-serve brand, Tinley™ ’27, pays respect to the year 2727 BC, which is the earliest recorded use of medical cannabis. In addition, it is a nod to the year 1927. This is the year Prohibition ended in the Province of Ontario, Canada, from which some of Tinley’s team members come from.

Tinley has its ready-to-drink Tinley™ Tonics Stone Daisy™ and High Horse™. Furthermore, it has its multi-serve Tinley™ Elixirs, Coconut Cask, Cinnamon Cask, as well as Almond Cask. Tinley™ Tonics ready-to-drink Stone Daisy™ Blue Agave Lime Tonic, and High Horse™ Spicy Ginger and Lime Tonic are non-alcoholic, single-serve versions of America’s favorite mixed drinks. They are crafted with natural flavors and lime essence. They are only 30 calories and contain 6g or less sugar per bottle. They also have a Micro-Dose of premium Pineapple Jack sativa, for a fast-onset, full flower experience. Each 12 fl. oz. bottle equals one Micro-Dose serving.

The Tinley™ branded cannabis-infused beverages are available in licensed dispensaries and delivery services throughout California. The Beckett’s™-branded non-THC (tetrahydrocannabinol) versions are increasingly available in mainstream food, beverage, and specialty retailers, and also on premises locations, throughout California and elsewhere in the USA.

In late May of this year, The Tinley Beverage Company announced the release of its financial and operating results for Q4 and fiscal year ended December 31, 2019, and provided revenue guidance on the 3-month period ended March 31, 2020 (Q1 2020). Capital Expenditures grew the Company’s asset base to more than $7 million, notably in Property and Equipment, by the completion of Tinley’s Phase 3 bottling facility development in Long Beach, California.

The Company provided Revenue guidance for Q1 2020 of more than $170,000.This is more than double all of fiscal 2019, with Gross Margins turning positive and surpassing 40 percent, propelled by growth across all product lines.

The Tinley Beverage Company, Inc. (TNYBF), closed Tuesday's trading session at $0.30, off by 7.8058%, on 7,1787 volume with 37 trades. The average volume for the last 3 months is 36,680 and the stock's 52-week low/high is $0.118299998/$0.546050012.

Bravatek Solutions, Inc. (BVTK)

Awesome Penny Stocks, MicroCapDaily, Stockopedia, InvestorsHub, Stockhouse, Seeking Alpha, OTC Markets, last10k, Wallet Investor, Nasdaq, TipRanks, Emerging Growth, GlobeNewswire, Barchart, TradingView, Stockwatch The OTC Reporter, Morningstar, CSI Market, Ceo.ca, Insider Financial, Simply Wall St and YCharts reported earlier on Bravatek Solutions, Inc. (BVTK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2007, Bravatek Solutions, Inc. is a security-platform business offering software, tools and services to global markets. The Company provides security, defense and information security solutions that assist corporate entities, governments and individuals in protecting their organizations and/or critical infrastructures against error, and also physical and cyber-attack. The Company previously went by the name Ecrypt Technologies, Inc. It changed its name to Bravatek Solutions, Inc. in October of 2015. Bravatek Solutions has its corporate office in Austin, Texas.

Bravatek’s principal operations focus on selling EcryptOne while also expanding its “MAP” (Market Alliance Program) enabling state-of-the-art complementary products and services to solidify their family of cyber security solutions. The Company engages in the marketing and distribution of security capabilities derived from market alliances that yield defense and information security software, hardware and services, and telecommunications services. Its products include software, hardware and services. They cover a range of industries, including e-mail security, user authentication, robotics, telecommunications and cyber breach protection.

The above-mentioned EcryptOne is a proprietary, patent-pending, GSA listed email protection software. EcryptOne’s been engineered from the ground up with a white-list mentality. It is a replacement for the messaging systems of the past. It makes use of modern technology to provide security and accountability - a core feature. The design of EcryptOne is for organizations operating in the contemporary world of compliance and oversight.

Furthermore, Bravatek Solutions has its Tuitio®. This is a new antivirus software. Tuitio monitors the behaviour of applications in the system rather than doing traditional signature matching like other antivirus software.

Recently, Bravatek Solutions announced that it entered into a Strategic Alliance Agreement with Z Systems (New Jersey-based). This agreement was entered into following Bravatek’s agreement with ZoonoUSA, a manufacturer and supplier of advanced technology products that offer germ protection, long after the product is applied, by creating a protective shield on the surface it is applied to. The shield lasts roughly 30 days on surfaces and 24 hours on skin, when natural exfoliation occurs. Z Systems’ capabilities were created to meet the present needs of industry concerning protecting employees, and the public in general, against unseen organisms.

Bravatek Solutions announced on February 27, 2020 that it received a detailed report from its partner, Zoono, that the third party, independent laboratory tests undertaken against COVID-19 showed that Zoono’s Z-71 Microbe Shield (the same Zoono technology used in Zoono hand sanitizer) is > 99.99% effective against COVOID-19. This product sanitizes and kills the virus.

Bravatek Solutions, Inc. (BVTK), closed Tuesday's trading session at $0.0067, up 109.375%, on 80,007 volume with 9 trades. The average volume for the last 3 months is 64,643 and the stock's 52-week low/high is $0.000099999/$0.387199997.

Integrity Applications, Inc. (IGAP)

Stockflare, Wallet Investor, MarketWatch, Simply Wall St, Stockopedia, PR Newswire, SmallCapVoice, Morningstar, Market Exclusive, Wallmine, Market Screener, OTC Markets Group, GuruFocus, Capital Cube, and YCharts reported previously on Integrity Applications, Inc. (IGAP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Integrity Applications, Inc. is the maker of GlucoTrack® - a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes. GlucoTrack® is a monitoring device that quickly measures and displays an individual's glucose level in about a minute without finger pricking or any pain. OTCQB-listed, Integrity Applications is headquartered in Wilmington, Delaware. The Company has a research and development (R&D) site in Ashdod, Israel.

Integrity Applications is focusing on three important initiatives - GlucoTrack Commercialization in Europe; GlucoTrack U.S. FDA (Food and Drug Administration) Approval; and a Product Roadmap. The Company’s initial principal emphasis is on the commercialization of GlucoTrack in Europe. GlucoTrack® has received CE Mark and KFDA approvals for type 2 diabetes and pre-diabetes. It is now in the early stages of commercialization in Europe, South Korea, as well as other geographies.

GlucoTrack® features a small sensor. This sensor clips to the earlobe and measures the user's glucose level using inventive and patented sensor technology. The measured signals undergo analysis using a proprietary algorithm and subsequently a calculated glucose level is displayed on a small handheld device the size of a small mobile phone.

The glucose results are stored in the device and used to project an estimated HbA1c level using a proprietary algorithm. The device can also display glucose values graphically. This allows the user to monitor glucose levels over time. GlucoTrack® is presently experimental in the United States. It is limited to investigational use only.

In December of 2018, Integrity Applications announced that it launched a Customer Experience Program in the Netherlands with its exclusive distributor MediReva and renowned clinical thought leaders in the field of diabetes care. The chief purpose of this program is to demonstrate real-world patient and health care professional experience with GlucoTrack® as a solution for daily glucose monitoring, and to further hasten commercialization and the reimbursement process in the Netherlands.

Integrity Applications, Inc. (IGAP), closed Tuesday's trading session at $0.35, up 34.6154%, on 500 volume with 1 trade. The average volume for the last 3 months is 4,289 and the stock's 52-week low/high is $0.239999994/$0.75999999.

CTD Holdings, Inc. (CTDH)

HotStockChat, Capital Cube, Dividend Investor, Greenbackers, Wall Street Resources, Marketwired, Pink Investing, YCharts, Nebula Stocks, The Street, 4-Traders, Business Insider, Guru Focus, Penny Stock Hub, Financial Content, Research Pool, Morningstar, Market Screener, and Wallet Investor reported earlier on CTD Holdings, Inc. (CTDH), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

CTD Holdings, Inc. is developing cyclodextrin-based products for the treatment of disease. This includes Trappsol® Cyclo™. The Company’s other divisions distribute and manufacture the trademarked Trappsol® and Aquaplex® cyclodextrins, cyclodextrin derivatives, and cyclodextrin complexes for biotechnology and life science companies engaged in the research, pharmaceutical, medical device, cosmetics, and nutrition markets. CTD Holdings is headquartered in Alachua, Florida.

The Company’s Trappsol® Cyclo™ is an orphan drug designated product. It is for the treatment of Niemann-Pick Type C (NPC). NPC impacts the brain, lung, liver, spleen, as well as other organs. Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. This includes peripheral artery disease, diabetic nephropathy, and acute viral infections.  

CTD Holdings’ other divisions operate the world's only cGMP pulse drying facility to produce UltraPure™ cyclodextrin derivatives and pharmaceutical grade Aquaplex® cyclodextrin complexes. Furthermore, they supply cyclodextrins to biotechnology and life science researchers internationally from the world's largest catalog of cyclodextrins.

CTD Holdings has started a multi-center worldwide Phase I/II clinical trial in Europe. This clinical trial is evaluating intravenous administration of Trappsol® Cyclo™ in NPC patients.

CTD Holdings announced in November 2018 its newest partner in support of its U.S. clinical program, Synteract. Synteract is a full-service Clinical Research Organization, which has an existing relationship with CTD in support of its Phase I/II clinical trial at sites in Israel and Sweden. Synteract will support CTD’s Extension Protocol, “An Open-Label Extension Study of the Long-Term Safety and Efficacy of Intravenous Trappsol® Cyclo™ (HPBCD) in Patients with Niemann-Pick Disease Type C (NPC-1),” in the U.S.

Recently, CTD Holdings announced its newest partner in support of its U.S. clinical program, United BioSource LLC (UBC). UBC provides pharmaceutical and home nursing services in support of clinical trials and other patient-centered initiatives. UBC will support CTD’s above-mentioned Extension Protocol.

CTD’s Extension Protocol for the Phase I trial was approved by the Food and Drug Administration (FDA) in April of 2018. The Protocol allows eligible subjects who have completed the Phase I trial in the U.S. to continue to receive intravenous administration of the Company’s Trappsol® Cyclo™, CTD’s proprietary formulation of hydroxypropyl beta cyclodextrin, until market registration.

CTD Holdings, Inc. (CTDH), closed Tuesday's trading session at $0.165, up 37.50%, on 858,577 volume with 147 trades. The average volume for the last 3 months is 91,580 and the stock's 52-week low/high is $0.079999998/$0.439999997.

Boston Therapeutics, Inc. (BTHE)

MissionIR,  Tiny Gems, SmallCapVoice, PennyStocks24,   FeedBlitz, Wall Street Mover,  RedChip, TaglichBrothers,  Stock News Now, TopPennyStockMovers, and Information Solutions Group  reported  earlier  on Boston Therapeutics, Inc. (BTHE), and  today we are reporting on  the Company, here at the QualityStocks Daily Newsletter.

Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. The Company’s product pipeline  centers  on developing and commercializing therapeutic molecules  that  address diabetes and inflammatory diseases. OTCQB-listed,  Boston Therapeutics is based in Lawrence, Massachusetts.

The Company’s  product pipeline includes BTI-320. This is a  non-systemic, non-toxic,  chewable complex carbohydrate-based compound. The design of it is to lessen post-meal glucose elevation. BTI-320 is a proprietary polysaccharide. 

BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes, which break down complex carbohydrates into simple sugars, reducing  the availability of glucose for absorption into the bloodstream. 

Boston Therapeutics  entered a  clinical trial agreement with Joslin Diabetes Center to be the lead clinic  in a Phase II study of BTI-320. In addition,  the Company’s  product pipeline  includes IPOXYN™. This is an injectable anti-necrosis drug. The design of it at first is to treat lower limb ischemia associated with diabetes.  

Boston Therapeutics’  product pipeline also  includes OXYFEX™. This product can serve as the only available oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events. OXYFEX™ is  the Company’s  veterinary facsimile to IPOXYN™.

Furthermore, Boston Therapeutics  developed and markets SUGARDOWN®. This is a non-systemic,  complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose.

SUGARDOWN®, in its present formulation, is a natural sugar blocker dietary supplement product made completely from a non-digestible sugar molecule, which can help people maintain healthier weight levels. It is the first chewable tablet of its kind. 

In 2015, Boston Therapeutics announced that its affiliate, Advance Pharmaceutical Company Limited (APC), began the  SUGARDOWN®  clinical trial in Hong Kong. Advance is evaluating the effect of  SUGARDOWN®  on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes.  The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong  (CUHK), Prince of Wales Hospital. 

In April 2017, Boston Therapeutics and  Advance Pharmaceutical announced the fully funded new trial plans to support the safety and efficacy of BTI-320, starting with a randomized, placebo-controlled, double-blinded, multi-center, global study on type 2 diabetic (T2D) patients.

More recently, Boston Therapeutics announced that effective sugar reduction with the investigative BTI-320 formulation necessitates only one tablet. Findings were confirmed by the most recent proof-of-concept study conducted in high-risk Chinese subjects with pre-diabetes. A formulation, in the form of a dietary supplement, is currently available as SUGARDOWN®, SUGARBLOCK and SUGARBALANCE in the Unites States and Asia.

Moreover, Boston Therapeutics also previously announced that it expanded its partnership with Advance Pharmaceutical Company Limited (APC) to distribute in Korea. Following the extension of the licensing and distribution agreement with APC, a registered formulation, marketed as a food supplement under the name SUGARBALANCE is now available in Korea. This significant shipment marks a start to the sales of SUGARBALANCE in the territory.

Boston Therapeutics, Inc. (BTHE), closed Tuesday's trading session at $0.0164, up 34.4262%, on 169 volume with 4 trades. The average volume for the last 3 months is 12,558 and the stock's 52-week low/high is $0.0052/$0.028999999.

TransAKT Ltd. (TAKD)

OTC Markets, Stockhouse, Barchart, and The Street reported on TransAKT Ltd. (TAKD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

TransAKT Ltd. is a manufacturer of highly unique agricultural equipment used to grow a broad array of vegetables and fruit employing simulated sunlight from LED lamps in an indoor proprietary hydroponic system. In addition, the Company is an international distributor of LED lighting products centered on serving the fastest developing market of commercial, hospitality, and outdoor lighting. OTCQB-listed, TransAKT is based in Hong Kong.

The Company’s commitment is to helping business owners protect the environment through superior energy efficiency - replacing current non-energy-efficient light sources with energy-efficient light sources. Additionally, TransAKT is focusing on eliminating the use of chemical fertilizers and pesticides utilizing the latest hydroponic agricultural technology and pure nutrients.

The nutrient solutions used in production with its hydroponic systems leave no heavy metal and chemical residues. TransAKT’s product line includes commercial production and home growing systems.

TransAKT’s wholly-owned subsidiary is Vegfab Agriculture Technology Co., Ltd. Vegfab was created in 2010 by a team of ecologically minded semiconductor specialists knowledgeable about LED materials.

Furthermore, TransAKT is looking for opportunities to develop a BIO-technology business in China. The Company says that the cordyceps business is one project with the greatest potential. It has engaged a team of approximately 10 experts in BIO technology engineering to develop an extended product mix. These products will debut in China in the next few years.

Vegfab’s product line includes systems for commercial production and a home growing system, which enables families to grow safe and clean fruit and vegetables in their homes. Vegfab products are the subject of numerous patents. These include ones for vertically wall-mounted LED lights, and ventilation systems for grow boxes.

Vegfab provides complete growing systems consisting of proprietary simulated sunlight LED boards; growing racks in diverse configurations for commercial and residential applications; environment control and plant nutrition control components; portable work tables and ladders; fruit and vegetable seeds and nutrition products; and vegetables.

Vegfab’s vegetable production factory in Yangmei City, Taiwan is the only mass production facility for vegetables in Taiwan. The facility utilizes innovative technology to produce exceptional yields from a very small space. Production is very efficient through the use of simulated sunlight from LED lamps, up to 85 percent automated.

TransAKT Ltd. (TAKD), closed Tuesday's trading session at $0.02, up 60.00%, on 14,113 volume with 6 trades. The average volume for the last 3 months is 2,420 and the stock's 52-week low/high is $0.0125/$0.029999999.

WRIT Media Group, Inc. (WRIT)

SeriousTraders, Tip.us, Real Pennies, StocksToBuyNow, Pennystockmania, Great Penny Picks, and SmallCapVoice reported earlier on WRIT Media Group, Inc. (WRIT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

WRIT Media Group, Inc. is a diversified media and software business whose shares trade on the OTC Markets. The Company’s portfolio of wholly-owned businesses includes Front Row Networks; Amiga Games; Retro Infinity, Inc.; and Pandora Venture Capital. WRIT Media Group is headquartered in Los Angeles, California.

WRIT Media’s operations include digital currency software development, including trading platforms and Blockchain solutions, content production and distribution; and video game distribution by way of mobile platforms. Its Front Row Networks produces and distributes live event programming for international digital broadcast to movie theaters and online streaming.

WRIT’s Amiga Games is a software company. Amiga is restarting the Amiga brand through publishing retro video games on smartphones and tablets. WRIT’s Retro Infinity is a video game distribution site. It publishes video games from Amiga, Atari and other "retro" brands on contemporary smartphones, tablets and consoles.

Additionally, WRIT’s Pandora Venture Capital is a financial technology company. Pandora has an emphasis on its digital currency, Pelecoin, a new generation of digital currency, Blockchain technology solutions, and also the CrypFXPro trading platform. WRIT Media's proprietary CrypStock digital trading platform will provide the technology that will support the creation and trading platform for Pelecoin and other digital currencies.

WRIT Media Group plans to integrate its Pelecoin Blockchain technology into products and applications that can be used to make it as easy to spend digital currencies, cryptocurrencies, and Pelecoin, as it is to spend US Dollars. Through the Company’s acquisition of Pandora Venture Capital, WRIT assumed a skilled management team with backgrounds in payments, telecom, and digital currency.

Recently, WRIT Media Group announced a number of technology innovations within its Pelecoin cryptocurrency system. The Company plans over the next year to enhance its software platform through adding more features and by expanding its ecosystem through new products.

DWRIT Media's development team has also built the core functionality of its digital currency system. The Company now offers a new feature that enables users to mine four cryptocurrencies at the same time by employing Pelecoin's proprietary mining algorithm software. The core system is complete. The foundation is ready for Pelecoin to expand and become a strong platform suitable for broader adoption, with updated core features and extensive new ones for its ecosystem.

WRIT Media Group, Inc. (WRIT), closed Tuesday's trading session at $0.0134, up 76.3158%, on 201 volume with 2 trades. The average volume for the last 3 months is 6,279 and the stock's 52-week low/high is $0.006599999/$0.0228.

American Power Group Corp. (APGI)

Marketbeat.com, Stock News Now, and SmallCapVoice reported on American Power Group Corp. (APGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, as well as off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts and lists on the OTC Markets Group’s OTCQB.

The Company’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run simultaneously on diesel and different kinds of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time. It is a ground-breaking non-invasive energy enhancement system.

American Power Group (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs) that can sell as heating fluids, emulsifiers, or be further processed by refiners. Via the Company’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.

Regarding American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad collection of engine models and end-market applications demands no engine modifications.

American Power Group Corp. (APGI), closed Tuesday's trading session at $0.015, up 50.00%, on 38,600 volume with 6 trades. The average volume for the last 3 months is 19,060 and the stock's 52-week low/high is $0.004699999/$0.019799999.

The QualityStocks Company Corner

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element (NASDAQ: NETE), a global financial technology and value-added solutions group, released its financial report for Q2 2020 (http://ibn.fm/d1h9G), the period ended June 30, 2020; NETE also provided more clarifying information about its pending merger with Mullen in an Aug. 19 shareholder letter (http://ibn.fm/W1ahe).

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. The company’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element chairman and CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked on Deloitte’s Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in both 2017 and 2018, during which the company grew 190 percent and 183 percent, respectively. The company credits its progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

Net Element was also listed among South Florida Business Journal’s 2016 fastest growing technology companies.

Leveraging its suite of application performing interfaces (APIs) and connectors, Net Element powers commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Leading this innovation is chairman and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations like Aptito to e-commerce and retail payment transaction processing brands like Payonline and Unified Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Tuesday's trading session at $7.11, up 6.4371%, on 199,658 volume with 1,161 trades. The average volume for the last 3 months is 1,726,681 and the stock's 52-week low/high is $1.472/$20.0783996.

Recent News

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER)

The QualityStocks Daily Newsletter would like to spotlight The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER).

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its flagship brand, Alkaline88(R), will be available in 1-gallon and 1-liter sizes at all 123 Fareway store locations across Illinois, Iowa, Minnesota, Missouri, Nebraska, and South Dakota. To view the full press release, visit http://cnw.fm/W3FOg

Founded in 2012, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88®, is a leading premier alkaline water brand available in bulk and single-serve sizes, along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88® delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked label ‘Clean Beverage’. Quickly being recognized as a growing lifestyle brand, Alkaline88® launched A88 Infused™ in 2019 to meet consumer demand for flavor-infused products. A88 Infused™ flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched the A88CBD™ brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full and broad-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, tinctures, capsules, gummies and powder packs.

Innovation and Expansion

Founded in 2012, The Alkaline Water Company began with a mission to create the best-tasting water in the world. At the time, there were two emerging trends in health-conscious consumers: a growing interest in the alkaline diet and perceived health benefits of pink Himalayan rock salt. By combining these two concepts in an alkaline water and trademarking the name Alkaline88, The Alkaline Water Company began offering what it calls the smoothest tasting Clean Beverage™ in the U.S. enhanced-water category.

Now a top bulk alkaline-water brand (the company reported record sales in March and April 2020, surpassing March and April 2019 numbers by 114% and 171%, respectively), The Alkaline Water Company is committed to growing its national footprint through innovation and expansion. That mindset was evident as the company introduced eco-friendly aluminum bottles and branched out into flavor-infused waters; the company currently offers six different flavors: peach/mango, lemon/lime, raspberry, watermelon, blood orange and lemon.

The company’s commitment to innovation may be most evident in its newest product line: A88CBD. This line of CBD-infused products includes tinctures, capsules, gummies, salves, balms, hand and foot lotions, essential oils, bath bombs and bath salts, as well as CBD-infused drinks, water and beverage shots. These quality, CBD-infused offerings are all made with lab-tested, full-spectrum hemp and are conveniently packaged and perfect for on-the-go or at home use.

In addition, The Alkaline Water Company has implemented an aggressive growth strategy, with numerous organic initiatives focused on national multichannel, mass-market expansion through a direct-to-warehouse model and co-packing facilities that are strategically located within 600 miles of 95% of the U.S. population. In addition to this strong brick-and-mortar approach, the company recently launched a B2C e-commerce platform (www.A88CBD.com) and aggressive digital-marketing campaigns.

Clear Advantages in a Growing Market

With consistent growth year over year, the company reported $32.2 million in revenue in fiscal 2019 and has emerged as a growth leader in the functional (value-added) waters space, which is the fastest-growing segment of the bottled water industry.

The Alkaline Water Company’s efforts are focused on its clear competitive advantages, including its strong marketing (the inclusion of alkaline in product names); existing grocery channels, which feature excellent relationships and a nationwide broker network; distinctive branding; proprietary technology, which produces great-tasting, high-quality water, infused drinks and other products; and price, with a broad range of products in all formats, from bulk bottles to single serve.

As the company focuses on strategic growth, it is eyeing the impressive potential of a market that is on a strong upswing. Annual bottled water sales have now surpassed soda consumption, with soda sales in the United States having declined by $1.2 billion over the past five years. Some research indicates that the global bottled water market will reach an estimated $280 billion this year, while the CBD market is forecast to top $20 billion by 2024.

With its products available in all major trade channels, including grocery stores, drug stores, c-stores and big-box retailers, The Alkaline Water Company is also looking to expand into new spaces, such as health and beauty, hospitality and specialty retailer locations.

Seasoned Management Team

The Alkaline Water Company is led by an experienced team focused on the company’s core strategy of building a national retail footprint and extending its lifestyle brands into other consumer packaged goods categories.

Richard A. Wright, President, CEO and Co-Founder of The Alkaline Water Company Inc., oversees all aspects of the business, successfully guiding the company through strategic opportunities and delivering greater than 50% growth since the company’s inception. A passionate and versatile leader with a strong track record of innovation, collaboration and achieving goal-driven results, Wright is a serial entrepreneur with more than 41 years of experience. Early in his career, he spent years at one of the ‘Big Four’ accounting firms, working his way up to Regional Director of Tax and Financial Planning. As a CPA, entrepreneur and former CFO, Wright brings extensive knowledge of finance, operations, sales and marketing to the team, and he has participated in hundreds of M&A transactions throughout his career.

David Guarino, CFO, Secretary, Treasurer and Director, earned a Bachelor of Science in accounting and a Master of Accountancy from the University of Denver. From 2008 to 2013, Guarino was President and a Director of Kahala Corp., a worldwide franchisor of multiple quick-service restaurant brands with locations in 49 states and more than 25 countries. From 2014 to 2015, Guarino was President of HTI International Holdings Inc., a technology company focused on forward osmosis water filtration technology.

Frank Chessman, National Sales Manager, is a graduate of the University of Southern California’s Marshall School of Business. He spent 25 years with Ralph’s Grocery, Kroger’s largest division, working at many levels before ultimately becoming Vice President of Advertising & Marketing. He then served 14 years as Executive Vice President at Simon Marketing. Chessman has more than a decade of experience in the beverage manufacturing industry.

Brian Sudano, Director, is managing partner of Beverage Marketing Corporation and BMC Strategic Associates. Sudano’s experience covers nearly the entire beverage industry, from energy drinks to wine, with special expertise in beverage alcohol by virtue of varied industry experience across a broad range of projects. Sudano manages several major clients, providing ongoing strategic and market advice and leading projects in strategic planning, market entry analysis and planning, sales/distribution, business modeling, brand repositioning and international opportunity assessment. He has spoken at many beverage industry events and is a contributing editor at Beverage World magazine.

Aaron Keay, Chairman, has been a successful investor, entrepreneur and financier to multiple small cap and startup companies over the last decade. During his time with these companies, he served in advisor, board-member and senior-management roles. His experience ranges across multiple sectors in mining, biotech, health and wellness, tech and cannabis, where he has invested and raised more than $500 million.

The Alkaline Water Company Inc. (NASDAQ: WTER), closed Tuesday's trading session at $1.52, up 2.0134%, on 1,321,637 volume with 3,907 trades. The average volume for the last 3 months is 1,713,532 and the stock's 52-week low/high is $0.400000005/$2.79999995.

Recent News

Pac Roots Cannabis Corp. (CSE: PACR)

The QualityStocks Daily Newsletter would like to spotlight Pac Roots Cannabis Corp. (PACR).

In the late 1860s, Friar Gregor Mendel, an Augustinian monk and scientist living in a monastery in the depths of the Austrian empire, set about cross-breeding different species of garden pea plants – an experiment which would ultimately plant the seed for genetic modifications in modern agriculture. Over 150 years later, the cannabis industry is picking up from where Friar Mendel left off. PacRoots Cannabis (CSE: PACR), a Canada-based company, has sought to adopt a genetics-focused approach towards producing premium quality cannabis products—positioning itself to become a trailblazer in providing industry-leading strains not currently available in the regulated market. Also today, CannabisNewsWire released a report on the company detailing how PacRoots has announced a private placement of units, the proceeds of which are intended to be used for upcoming projects and general working capital. According to the announcement, released by Pac Roots CEO Patrick Elliott, the placement of units will be at a price of C$0.25 per unit for gross proceeds totaling up to $2 million, subject to an overallotment option. To view the full press release, visit http://cnw.fm/N0HZ7

Pac Roots Cannabis Corp. (CSE: PACR) is a Canadian cannabis company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach.

The company began operations in 2012, with activities primarily directed toward exploration and development of mineral properties in Canada. Today, it is focused on cannabis and hemp cultivation, leveraging high-end genetics and specialized cultivars to produce top quality products. Pac Roots has announced multiple promising initiatives in recent months, including its formation of an outdoor premium hemp joint venture with partner Rock Creek Farms in British Columbia, Canada, and its agreement to acquire all issued and outstanding shares of a firm holding 250 acres of land in the famed Fraser Valley Region of British Columbia.

Pac Roots is also in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through an elite line of 350+ unique, high-grade cultivars. Pac Roots expects to receive a cultivation license for the facility in the fourth quarter of 2020.

High-End Selectively Bred Genetics

Pac Roots focuses on high-end genetics in order to maximize the quality of its products while maintaining high yields and profit margins.

Through the process of artificial selection, farmers and cultivators have been adapting their plants to develop particular phenotypic traits for generations. Historically, this practice was restricted to underground cannabis producers developing their own strains.

The legalization of the cannabis industry has given producers access to thousands of cultivars located throughout the world while accelerating research into cannabis genetics. By carefully selecting strains, growers can control the size, color, smell, density and texture of cannabis buds, thereby creating distinctive, premium cannabis products.

Plants are bred to thrive in specific growing environments. This maximizes the yield of high-quality, resilient cannabis. Medical cannabis strains can also be tailored for specific medicinal purposes.

A strategic partnership with Phenome One, a plant breeding management and analytics firm, gives Pac Roots access to some of the world’s best cannabis genetics from the largest genetic library in Canada. The company is using these genetics to develop unique strains featuring a variety of beneficial characteristics.

The company’s 350+ licensed live cultivars and over 1,800 seed varieties are the result of a meticulous gene selection process, through which as many as 600 individual plants may be grown to produce a single strain. Selecting optimized genetics in this way provides benefits beyond simply producing a high-end product. In addition to potency and bud quality, cannabis plants are bred for yield and resilience. By selecting genetics that result in larger and more numerous buds on each plant, Pac Roots is able to grow more cannabis per grow light.

Breeding plants to be more resilient also reduces the cost and labor required. These factors, combined with the premium price point associated with top-quality cannabis, have the potential to improve Pac Roots’ overall profit margin.

Partnership with Phenome One

Pac Roots has secured its cultivars through a strategic licensing agreement with Phenome One. Under the agreement, Pac Roots has unlimited access to Phenome One’s live genetic library, including any of Phenome One’s cultivars and its growing, breeding and cloning IP.

Phenome One is an agricultural technology company focused on providing software solutions to seed companies. Phenome One’s platform gives its partners access to a massive database of detailed information on over 350 unique cannabis cultivars to support each stage of the breeding process. Each cultivar has been laboratory analyzed and rigorously field-tested, with data going back more than 30 years.

Using Phenome One’s data, Pac Roots plans to grow a variety of cannabis plants optimized for certain traits. One such trait will be plants with an abundance of cannaflavin, a rare terpene with high anti-inflammatory properties. Phenome One’s library could enable Pac Roots to produce plants that are bred to thrive in a range of different growing climates, including plants suited to grow in cold weather and plants that are resilient to region-specific fungi.

Joint Venture with Rock Creek Farms of British Columbia

Pac Roots recently entered a definitive investment agreement with Rock Creek Farms, a reputable agricultural enterprise, for a 100-acre commercial hemp operation in Rock Creek, British Columbia. The growing space is located in the highly lucrative farming area known as the ‘Golden Mile’ in the South Okanagan Valley of British Columbia. (http://nnw.fm/Gbf9I).

Under the agreement, the two companies have formed an outdoor premium hemp joint venture company to which Pac Roots is providing an aggregate of $450,000 in capital and Rock Creek Farms is contributing two commercial leases for 100+ acres of growing space, along with cultivation licenses, agricultural infrastructure and equipment, consulting services, intellectual property relating to hemp operations and proprietary biomass storage methods. Pac Roots holds a 60 percent interest in the project.

About 127,500 premium hemp CBD seedlings were planted across 100 acres as of early July 2020. The joint venture is planting a premium grade CBD hemp variety utilizing the rich native soil and both traditional and custom farming techniques.

“Our operational partners at Rock Creek Farms bring decades of generational farming expertise in one of Canada’s pre-eminent growing regions,” Pac Roots President and CEO Patrick Elliott said in a news release detailing the venture. “It will be an exciting outdoor growing season for the joint venture as we anticipate a successful harvest in the fall.”

Infinite Development Possibilities at Fraser Valley Property in British Columbia

In mid-July 2020, the company initiated a share purchase agreement with 1088070 BC. LTD. (“1088”) and its shareholders for the acquisition of all issued and outstanding shares of 1088 (http://nnw.fm/xlpw7). Notably, 1088 owns and controls 250 acres of land spread over nine parcels in the Fraser Valley Regional District.

The Fraser Valley Regional District is one of the most productive and intensively farmed areas of Canada, offering access to high-quality soil, favorable climate, water and a local market of 2.5 million people. Agriculture in this region yields an annual economic value of more than $3 billion.

The closing date for the transaction is slated for September 4, 2020, after a 51-day due diligence period. According to Elliott, the addition of such a significant package of land is a major step for Pac Roots.

“This land has no zoning restrictions and is not situated within the agricultural land reserve, which provides for infinite development possibilities,” Elliott added in a July 2020 news release.

Board of Directors member Chad Clelland also welcomed the acquisition, adding that between Fraser Valley and Rock Creek – both of them among the most productive agricultural regions in Canada – Pac Roots is very well positioned for production and the future development of its hemp and cannabis infrastructure.

The RAD Americas Genetic Program – Research and Development in Americas Genetic Program

Pac Roots intends to deploy a global R&D program focused on rigorously testing elite strains in various rich agricultural regions throughout the Americas, with a goal of mass selection to achieve the utmost environmental resilience while achieving notable quality and yields. From seed to software, collection data, proprietary techniques and custom nutrient formulas, Pac Roots and Phenome will provide the specific knowledge to cultivators in different climates in order to achieve optimal yields for THC, CBD, CBG and other unique cannabinoids. R&D from global testing programs situated throughout the Americas will allow the partnership to deploy and stress test a range of suitable cultivars in the world’s lowest cost outdoor growing regions.

The company expects an industry shift in 2020 from the COVID-19 global pandemic. The ‘new normal’ will bring more focus on efficiencies and optimal yields to deliver a cost effective, high quality product to the end user. There has been much to be learnt from the inefficiencies in the cannabis industry in recent years, which have been detrimental to the credibility of the sector. Pac Roots is well positioned to enter the scene and take advantage of the deficiencies, reinforcing the notion that genetics and flawless growing techniques are paramount to success. Genetics and systems innovation may be the most overlooked components when comparing cannabis to other established agricultural crops. Pac Roots plans to invest into cannabis R&D to ensure a solid foundation is built that will be used by cannabis farmers worldwide.

Through its RAD Americas Development and Innovation, Pac Roots is focused on:

  • Deploying one of the largest live genetic libraries in Canada, diversified for high yield output and unique climates
  • Continued stress testing for indoor, high yield, THC and medicinal genetics
  • Continued stress testing for outdoor, high yield, THC and medicinal genetics
  • Exotic, genetic cloning for the luxury, high margin, cannabis flower market
  • Psychoactive/medicinal ratio testing for effect and
  • Unique Cannabinoid and terpene elevation and isolation.

Through its RAD Americas Field Testing System, the company is focused on:

  • Global testing in different microclimates to assess genetic and complete systems for optimal yields
  • Data collection, testing and optimization to prove process for commercial implementation and
  • High quality yield testing for THC, CBD, CBG and other unique medicinal cannabinoids.

Lake Country Cultivation Facility near Kelowna, British Columbia

Pac Roots is in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through its line of high-grade cultivars. Pac Roots plans to submit a video evidence package of the facility build under Health Canada’s Cannabis Tracking and Licensing System, and the company expects to acquire its cultivation license in the fourth quarter of 2020.

Lake Country is a municipality located just outside of Kelowna in the Okanagan region of British Columbia. For decades, the region’s favorable growing climate has made it a hub for cannabis cultivation. As the Canadian legal cannabis industry ramps up, the Okanagan region is attracting attention from dozens of cannabis companies, including some of the industry’s biggest names. The region’s strong agricultural history has left it rich with experienced agricultural workers and an abundance of Agricultural Land Reserve (ALR) property.

Management Team

Patrick Elliott, MSC, MBA, President and CEO of Pac Roots Cannabis, is also the President & CEO of Lexore Capital Corp., a private resource and cannabis investment company, as well as Phenome One Corp., a full-service cannabis farming company focused on elite strain selective breeding. Elliott brings over 15 years of corporate finance, mineral exploration and financial markets experience to the Pac Roots team. He is a graduate of the University of Western Ontario in geology and holds an MSc. in mineral economics and an MBA from Curtin University of Technology in Perth, Australia. Elliott specializes in economic resource evaluation, financial modeling, CAPEX estimation, corporate development and finance. Combined with his technical knowledge, Elliott has a wealth of contacts in the financial sector.

Marc Geen, Founder and Strategic Operations Advisor, is a fourth-generation British Columbia farmer who has been active in the legal medical marijuana industry for more than 10 years – consulting on, complying with, and participating in the MMAR, MMPR and ACMPR programs. Prior to co-founding Speakeasy Cannabis Club Ltd., Geen spent 14 years as Head of Operations for Kettle Mountain Ginseng Ltd., one of North America’s largest ginseng producers. With the experience gleaned from a long career in large scale commercial farming, Geen has been able to apply many cost-effective farming practices to the outdoor, indoor and greenhouse cultivation of cannabis. Geen is also the co-creator of a full line of cannabis extract products designed under ACMPR regulations.

Matt McGill, Director, has a strong background in both commercial and residential real estate and has played a major role in many development projects. McGill, through McGill Realty, has established a tremendous commercial and residential outfit servicing British Columbia’s Fraser Valley and the lower mainland. McGill is skilled at crafting strategic financing options for corporations and has a substantial network of retail and institutional clients.

Chad Clelland, Director, has experience in the sector dating back to 2009, when he purchased Medicalmarijuana.ca, which became an information portal for thousands of patients, doctors and growers. Through this company, he and his team have helped thousands of Canadians find legal, safe medication. His team also consulted, designed and submitted dozens of applications to the government under the MMPR, ACMPR and Cannabis Act. In 2011, Clelland co-founded Greenleaf Medical Clinic, which is now recognized as a training facility by the University of British Columbia and offers preceptorships to physicians, nurse practitioners and pharmacists. He also co-founded Folium Life Science in 2013, an approved Canadian Licensed Producer. His roles in these organizations have included Chief Operating Officer, head of security, alternate master grower and alternate responsible person in charge.

Josh Bromley, Senior Cultivation Strategist, is a second-generation farmer with over two decades of experience farming, breeding, cultivating and selecting unique cultivars for the medical community. He is an expert in plant science and possesses a comprehensive knowledge of cultivars and a mastery of medicinal implementation. Bromley has developed proprietary farming systems, as well as low cost/high output nutrient systems. Through thoughtful design and engineering, he has been able to consistently show improvements in crop yields, pathogen resiliency and quality.

Pac Roots Cannabis Corp. (PACR), closed Tuesday's trading session at $0.25, up 8.70%, on 16,181 volume with 4 trades. The average volume for the last 3 months is 31,822 and the stock's 52-week low/high is $0.11/$0.72.

Recent News

The Movie Studio Inc. (OTC: MVES)

The QualityStocks Daily Newsletter would like to spotlight The Movie Studio Inc. (OTC: MVES).

The Movie Studios (OTC: MVES), an independent motion-picture production and distribution company, continues to solidify its industry position as more entertainment consumers cut the cord and gravitate to Video on Demand (“VOD”). MVES recently filed an application with the U.S. Patent and Trademark Office as it seeks to protect its recognizable name, insignia, phrase and logo in preparation for the release of its new app that will showcase its motion picture content to a loyal global audience. To view the full article, visit: http://nnw.fm/JTqa8.

The Movie Studio Inc. (OTC: MVES) is a vertically integrated motion picture production company focused on acquiring, developing, producing and distributing independent motion picture content for worldwide consumption via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. The company is currently engaged in establishing its own OTT VOD platform to integrate both its own and aggregated feature film projects, television programming and other media intellectual properties. The Movie Studio is disrupting traditional media content delivery systems with its digital business model of motion picture distribution, and the company intends to create a direct server access platform of its content with geo-fractured territories for worldwide distribution.

The company has launched The Movie Studio App on Google Play and the App Store, enabling users to both view the company’s content and potentially become part of it. The app is in the completion stage, and The Movie Studio is conducting its final beta test of the app’s unique “audition submission” function, leveraging the company’s “Watch Our Movies, Be in Our Movies!” content platform and “Everyone’s a Star” campaign, which will be marketed via social media. Using the app, subscribers can upload a thumbnail photo of themselves along with a selfie video audition submission that showcases them reading character dialog. Audition submissions will then be reviewed by producers for possible participation of the auditionee in upcoming feature films.

The audition submission function provides the subscriber the ability to disrupt traditional motion picture casting and management, enabling access to participation in The Movie Studio’s independent motion picture and media content. At the same time, for the company this significantly reduces capital expenditures associated with those traditional media mechanisms. The Movie Studio’s unique business model capitalizes on the global demand for film content through the production and distribution of its own films while also providing opportunities for direct viewer involvement in its content.

The company operates using a growth-by-acquisition strategy that includes:

  • Purchasing legacy film libraries.
  • Upgrading acquired films to 4K resolution and remonetizing with “new” film content on popular VOD streaming platforms across the internet.
  • Strategic partnerships and media content alignment with other OTT platforms and cross-collateralization of leverageable media assets for worldwide distribution.
  • Producing micro-budget motion picture content with substantial production value utilizing new 4K technology and the company’s extensive legacy resources and unique production process, thereby significantly reducing capital expenditures while allowing for the potential of significant return on investment (ROI) with one successful production.
  • Controlling its revenue streams through server-driven geo-fracturing global territories and its own OTT platform.

Currently, The Movie Studio is producing three upcoming feature films: “Cause and Effect,” “The Last Warhead” and “PEGASUS” — all with completed electronic press kits and pitch decks and fully produced motion picture-quality trailers ready for talent, distribution and financial integration.

The company has been successful in producing, casting and distributing its films on major SVOD platforms without recognizable stars, which reduces capital expenditures. However, The Movie Studio intends to integrate recognizable stars into the productions at value propositions either pre- or post-completion of the intellectual property.

Through successful beta testing, The Movie Studio has monetized film assets on the Amazon, tubi tv, Comcast and Showtime platforms.

The company’s proposed server-based model will provide licensing payment from global territories without third-party distribution fees, which have traditionally been as high as 35%.

Founded in 1961 and formerly known as Destination Television, Inc., the company changed its name to The Movie Studio, Inc. in November 2012. The Movie Studio is headquartered in Fort Lauderdale, Florida.

Cord-Cutting Creates Opportunity for VOD Players

Consumers are no longer content waiting for their favorite programming to come on the air – they expect instant streaming access where and how they want it. This has led to increased “cord cutting,” with consumers severing ties with their traditional pay TV providers in favor of digital streaming services.

With the advent of smart TVs with app integration, consumers can now watch what they want to watch when they want to watch it, fracturing traditional cable bundling mechanisms.

With pay TV usage steadily declining – satellite and cable TV businesses in the United States lost approximately 6 million customers in 2019 alone – streaming platforms are poised to potentially replace traditional pay TV distribution models altogether. Approximately 12,000 U.S. consumers are cutting the cord every day.

As this shift in media delivery continues and as digital devices become more sophisticated and bandwidth increases, VOD platforms have the potential to scale significantly. The Hollywood “streaming wars” of recent years have created an environment in which smaller competitors, like The Movie Studio, are able to emerge as major brands.

The Movie Studio Inc. (OTC: MVES), closed Tuesday's trading session at $0.0149, up 24.1667%, on 932,863 volume with 49 trades. The average volume for the last 3 months is 204,400 and the stock's 52-week low/high is $0.006099999/$0.0412.

Recent News

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (OTCQB: SGMD) was featured today in the 420 with CNW by CannabisNewsWire. A study found that states that had legalized cannabis were less likely to experience growth in vaping related lung injuries in the past year in comparison to states that prohibited marijuana use. The study strengthened the arguments of advocates that called for marijuana reform, stating that its legalization and regulation reduced the potential risk of consumers using possibly dangerous and contaminated products.

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Tuesday's trading session at $0.0023, up 6.9767%, on 55,817,935 volume with 187 trades. The average volume for the last 3 months is 70,736,273 and the stock's 52-week low/high is $0.001599999/$0.021999999.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX’s (NASDAQ: SRAX) BIGtoken, a permission-first consumer data-management platform, released a new consumer research report comparing its users’ TV and movie-consumption behaviors one month versus four months into the global pandemic. According to the update, BIGtoken surveyed its U.S. user base in April and again in August to compare results and understand how the pandemic has impacted TV and movie consumption. Among the results, which can be downloaded in the full report at http://nnw.fm/vx2Jd, 46% of BIGtoken’s survey respondents indicated that they were video streaming more in August 2020 than they were four months prior. To view the full press release, visit http://nnw.fm/6xYZr

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Tuesday's trading session at $3.02, off by 0.66%, on 93,970 volume with 257 trades. The average volume for the last 3 months is 88,043 and the stock's 52-week low/high is $1.04999995/$3.28999996.

Recent News

InsuraGuest Technologies, Inc. (TSX.V: ISGI)

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Technologies, Inc. (TSX.V: ISGI).

InsuraGuest Technologies (TSX.V: ISGI) is set to expand the reach of its insurtech product in the hospitality sector after signing full-service insurance firm Swarts, Manning & Associates for its agency/broker program. According to a company new release, the agreement was signed through the company’s wholly-owned subsidiary InsuraGuest Insurance Agency, LLC (http://nnw.fm/heNQi). Also today, NetworkNewsWire released a report on the company detailing how InsuraGuest has completed integration of Hostfully Inc.’s end-to-end, property-management platform with InsuraGuest’s Application Programming Interface (“API”) (http://nnw.fm/Jb7g1). To view the full article, visit: http://nnw.fm/sJVdV

InsuraGuest Technologies, Inc. (TSX.V: ISGI) is a leading global SaaS (Software-as-a-Service) company leveraging its proprietary, flagship insurtech (insurance + technology) software, InsuraGuest, which is integrated with the property management systems of hotels and vacation rentals to deliver custom Hospitality Liability coverages.

InsuraGuest’s Hospitality Liability coverages are purchased by hotels and vacation rental properties, which can address claims from guests and their room occupants. The combination of the integrated software and customized insurance provides the property liability coverages the guests benefit from in the event a loss is incurred during their stay.

The Hospitality Liability policy is offered through integration of InsuraGuest’s API with the clients’ property management systems. InsuraGuest’s platform is currently capable of integrating with approximately 71 different hotel and vacation rental property management systems, giving it access to millions of rooms worldwide.

InsuraGuest continues to pursue expansion opportunities in the United States, and has plans to expand to its distribution platform and Hospitality Liability coverages to the United Kingdom and Europe regions by third quarter 2020, as well as expansion into Asia by the end of 2020.

Protection that Enhances the Guest’s Experience

InsuraGuest’s Hospitality Liability coverages add a layer of protection for the property on a primary basis, should a guest experience an accident or theft while staying at an InsuraGuest member hotel or vacation rental property.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights stayed in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion stayed nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United States, where there approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit that are not the properties fault.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Hospitality Liability policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Investment Consideration

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a Bachelor of Science in consumer studies with an emphasis in architecture as an undergraduate at the University of Utah. He subsequently earned his MBA. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Logan Anderson, CFO & Director
Logan Anderson (bachelor’s degree in communications, accounting and economics) holds the designation of ACA with the Chartered Accountants of Australia and New Zealand. He began his career as an associate chartered accountant in New Zealand and then Canada. This was followed by his position as controller of a management services company which was responsible for the management of numerous private and publicly traded companies. Since 1993, Anderson has served as president of Amteck Financial Corp. (and its predecessors), a private financial consulting services company servicing both private and public companies. He is a former director of 3D Systems, Inc. (NYSE: DDD), and was formerly a founder, officer, and director of Worldbid.com. Anderson has also been involved in raising funds for numerous private and public companies in all stages of their development and has been an officer and director for numerous public and private companies over the past 40 years.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends. Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Tony Sansone, COO & VP of Finance
Tony Sansone has over 30 years of financial, operations and business development experience which includes serving as CFO in the health care, foodservice distribution, manufacturing and technology sectors, including public company experience. He has held senior finance positions in the banking, telecommunications, medical products, and food & drug retailer industries, closing over $430 million of private debt, equity and line of credit financings and over $350 million of a merger, acquisitions, real estate and state incentive transactions, including due diligence, negotiations, closing, and integration. Sansone coordinated and was the executive sponsor for four ERP implementations and multiple other best-in-class software & technology solutions. He received his MBA from the University of Utah and a Bachelor of Science in accounting from Utah State University. Sansone also currently serves as president-elect of the Utah Chapter of Financial Executives International and a past president and current member of the board of trustees for Catholic Community Services of Utah. He is the proud father of three children.

Christopher J. Panos, Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018 and as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Jennifer Epperson, Vice President of Sales
Jennifer Epperson has over 20 years of B2B sales experience with exceptional success history. She has grown and developed sales territories across multiple industries. Her ability to find and develop strategic relationships has given her top-level performance throughout her career. Epperson’s passion and knowledge provide an inherent ability to connect and retain relationships for the growth of the company. Throughout her professional career, she has achieved peak performance sales results and awards year after year. She captures the vision of the company and drives it forward with enthusiasm and expertise. Her commitment to providing an exceptional customer experience has been the key to her success.

Richard Matthews, Interim Financial Controller
Richard Matthews joined the InsuraGuest team in March 2019 as the interim financial controller. Leading the Finance and Audit team, Matthews is responsible for the delivery of financial services such as accounting, treasury, reporting, budgeting and insurance management, in accordance with legislative requirements and organizational policies and strategies. He has over 30 years of experience in providing professional services across a broad range of finance areas including compliance, business process, audit, and financial reporting. He holds a degree in accounting from the University of Utah and is a licensed CPA in the state of Utah.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.

Jim Kilduff, Board Advisor
James “Jim” C. Kilduff has nearly 40 years of experience in the insurance and risk management sectors. He is a dynamic and energetic team leader and builder with extensive experience in the changes affecting the insurance business through Gas, alternative distribution, insurtechs and program business. His skillset includes experience as chief insurance officer with Outdoorsy Insurance Group, CEO with Harbor Hill Solutions Inc., and senior vice president and chief marketing officer with State National Insurance Companies. His career has spanned MGA creation and management, insurance company management, business development and underwriting, primary insurance and reinsurance.

Don Archibald, Board Advisor
Don Archibald brings to InsuraGuest’s advisory board 54 years of experience as an insurance agent. Archibald is the founder and former owner of Archibald Clarke and Defieux (ACD Insurance), as well as the co-founder and former equity partner of Sussex Insurance, and an agent with Sussex since 2014.

InsuraGuest Technologies, Inc. (TSX.V: ISGI), closed Tuesday's trading session at $0.1467, off by 2.20%, on 3,000 volume with 1 trade. The average volume for the last 3 months is 302 and the stock's 52-week low/high is $0.079300001/$0.248799994.

Recent News

DarioHealth Corp. (NASDAQ: DRIO)

The QualityStocks Daily Newsletter would like to spotlight DarioHealth Corp. (DRIO).

DarioHealth Corp. (NASDAQ: DRIO) was featured today in a publication from BioMedWire, examining how several countries have had to put in place strict measures to curb the spread of COVID-19. Some of these measures include the restriction of movement and lockdowns. These measures have brought significant challenges to the less fortunate in most countries. Furthermore, several economies are crumbling, and some nations cannot comfortably feed their citizens.

New York and Israel-based DarioHealth Corp. (NASDAQ: DRIO) leads global digital therapeutics (DTx) with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The company’s strategic advantages include:

  • AI-powered digital solutions that drive durable behavior change in chronic disease patients, and
  • Personalized user experience at scale to make behavior change the path of least resistance.

Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.

Roughly 51,000 active, paying users manage their health with Dario’s platform that combines smartphone-connected vitals measurement, remote patient monitoring (RPM), lifestyle management tools, and AI-driven and human coaching to deliver improved clinical outcomes.

Among the most downloaded medical apps, the Dario platform is rated at 4.9 stars on the Apple App Store and features 11,000 reviews, along with a Net Promoter Score (a measurement of consumers’ willingness to recommend the product to others) that’s the highest in its field.

Company Strategy

Clinical studies demonstrate Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).

Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.

Proprietary data analysis provides valuable insights that not only improve health care providers’ medical capabilities but, through artificial intelligence, encourage patients to take evidence-based and highly personalized preventative measures that reduce risk, emergency room visits and preventable hospitalization.

Dario is now deploying its successful B2C platform in B2B2C, targeting employers and health plans with competitive advantages in cost, software and hardware.

The company estimates an annual addressable U.S. market of $72 billion, only 1% of which has been penetrated with digital therapeutics.

The strategic transition to B2B2C (from exclusively B2B) is intended to accelerate revenue growth by reducing Dario’s cost per acquisition per user and expanding margins.

Dario’s commitment to aggressive growth is also shown by its appointment of a new president, chief medical officer and head of sales for North America, all from a highflyer behavioral health company.

Key growth drivers planned include expansion of the company’s paying B2C subscriber base; lateral expansion into other chronic conditions that overlap with its core diabetes populations, such as hypertension, obesity and depression; and increased B2B2C penetration.

Financial Highlights

The company plans to leverage a massive opportunity for growth, with a global addressable market for digital therapeutics of roughly $108 billion. In the U.S. alone, that number is estimated at $72 billion, and only about 1% of that market has been penetrated.

Dario’s strategic transition to an SaaS membership business model increased gross profit by 87% in Q1 2020, as compared to the prior year. Membership revenue increased from 27.1% to 46.7% in the same period. The company is seeing improved operating efficiencies as it shifts focus to the B2B2C business model, and it expects average revenue per user per month (ARPU), which was $6 and $25 in 2019 and 2020, respectively, to reach $70.

Value to Consumers and Businesses

Dario continually evaluates and optimizes the value and return its platform delivers to consumers and businesses.

Consumers seeking to understand how their everyday behavior impacts their personal health and chronic conditions benefit from actionable feedback on how to improve health and better collaborate with health care providers.

Businesses looking to increase employee satisfaction, loyalty and productivity with fewer health-related absences take advantage of Dario’s services for employers.

Health care providers improve patient compliance using the platform’s interactive services that allow for greater monitoring, which improve engagement with patients at the right times and with the right treatments.

Health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs.

Recent Studies

The company recently presented the results of two new studies at the American Diabetes Association’s 80th Scientific Sessions, which showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. The results of these two studies demonstrate that the use of Dario’s therapeutic platform promotes behavioral modification, enhanced individual engagement and improved clinical outcomes.

Remote Patient Monitoring (RPM) Agreements

The Centers for Medicare & Medicaid Services recently approved RPM codes for Medicare patients, which enables physicians to bill for between-visit patient care.

This simplifies implementation of the company’s open and scalable AI-driven platform and further supports transition to the company’s high-margin, recurring SaaS model targeting B2B2C revenue channels.

Emergency COVID-19 FDA Guidelines Allow Self-Test Blood Glucose Meters

In an effort to preserve personal protective equipment (PPE) and reduce contact between health care providers and patients in hospital settings due to COVID-19, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters, including Dario’s smartphone-connected metering device, may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.

As a result, hospitals can now allow patients to self-test using their Dario blood glucose testing strips and smartphone-connected devices, or hospitals can issue patients Dario devices upon admission for COVID-19-related conditions.

Irregularities in blood glucose levels are suspected as a factor in the increased severity of potentially deadly COVID-19 complications. As such, a high priority is being placed on stabilization of patients’ blood glucose levels.

Awards and Recognition

DarioHealth’s Blood Glucose Monitoring System was voted as the ‘Best Glucometer for Data Management’ by Top Ten Reviews. Jeph Preece, senior editor at Top Ten Reviews, said, “The Dario app is the best data management system that I’ve seen. Compared to apps by popular brands, Dario’s system looks and feels like it’s years ahead of the curve.”

‘The Global Digital Health 100’, an annual award sponsored by the reputable Journal of Health, recognized DarioHealth as a leader among health technology companies demonstrating the greatest potential to change the way that health care is delivered.

DarioHealth Corp. (DRIO), closed Tuesday's trading session at $15.56, off by 4.6569%, on 124,938 volume with 779 trades. The average volume for the last 3 months is 254,798 and the stock's 52-week low/high is $3.01999998/$22.4899005.

Recent News

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Trxade Group (NASDAQ: MEDS) will introduce a raft of potential new investors to the accomplishments of its growing brand in the medical technology space when CEO Suren Ajjarapu makes a 20-minute presentation on the company as part of the upcoming LD 500 Virtual Investor Conference.

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Tuesday's trading session at $5.56, off by 4.6312%, on 5,942 volume with 72 trades. The average volume for the last 3 months is 53,960 and the stock's 52-week low/high is $4.01000022/$11.6000003.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI) was featured today in a publication from BioMedWire, examining how a neural implant or brain implants are technological devices that are connected to a person’s brain. They are placed on an individual’s brain or connected to the brain’s cortex. This device then interacts with the brain’s neurons. They can be inserted through an injection or surgery. Neurons are cells responsible for relaying information in a person’s body using electrical signals.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Tuesday's trading session at $0.928, off by 14.0741%, on 1,882,589 volume with 2,823 trades. The average volume for the last 3 months is 960,746 and the stock's 52-week low/high is $0.839999973/$6.25.

Recent News

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

PowerBand Solutions Inc. (TSXV:PBX) (OTCQB:PWWBF) (Frankfurt:1ZVA) ("PowerBand", "PBX" or the "Company") is pleased to announce that HUB International Ltd. ("HUB"), the world's fifth largest insurance broker, will offer its personal lines automotive insurance solutions, on PowerBand's virtual transaction platform to drivers across the United States, and soon after Canada, through PowerBand's strategic partner, Texas-based D&P Holdings, Inc. ("D&P").

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÃœV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Tuesday's trading session at $0.17625, off by 1.7285%, on 14,550 volume with 5 trades. The average volume for the last 3 months is 82,880 and the stock's 52-week low/high is $0.038600001/$0.241600006.

Recent News

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK)

The QualityStocks Daily Newsletter would like to spotlight iClick Interactive Asia Group Ltd. (NASDAQ: ICLK).

iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced the commencement of a follow-on offering of up to 7,922,787 American depositary shares (the "ADSs"), with two ADSs representing one Class A ordinary share of the Company, par value US$0.001 per share (the "Offering").  

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider connecting worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfills various marketing objectives in a data-driven and automated manner, helping international and domestic marketers reach their target audiences. Headquartered in Hong Kong, iClick operates in 10 locations worldwide, including Asia and Europe.

iClick aims to become a fully integrated Enterprise and Marketing Cloud Platform in China, providing clients a full consumer-cycle solution. This is facilitated by two pillars’ growth strategy through two business segments: Marketing Solutions and Enterprise Solutions.

Marketing Solutions

Using data and AI-driven technology to help brands efficiently identify, target and acquire the right customers

As the leading programmatic marketing platform in China, iClick’s proprietary platform collects a wealth of data from multiple sources to precisely reach the right audience at the right moment, on the right channel and right device. Cross-screen search solutions capture critical micro-moments when users proactively search for what they need. This multi-dimensional approach to marketing allows iClick to effectively understand internet users and exponentially widen target audiences for its brand clients. Multiple monetization models available in the Marketing Solutions segment allow iClick to serve its clients in several ways, such as audience targeting.

Data-driven marketing is indispensable to marketers targeting specific audiences in China. More than 825 million internet users in China are anonymously profiled on iClick’s platform, which boasts cross-channel and cross-screen capabilities.

Enterprise Solutions

Enabling brands to efficiently manage their consumers through online and offline data integration and analysis, increase the repurchase rate, and enhance consumers’ loyalty

iClick’s Enterprise Solutions segment addresses enterprise needs in China, particularly focusing on “smart retail,” an expanding and innovating market involving the combination of online and offline consumers’ behavioral information. Enterprise Solutions support detailed profiling of customers, which facilitates data-driven business strategies, enhances business processes at various levels, and increases operational and marketing efficiency.

Enterprise Solutions leverages iClick’s proprietary platform that incorporates Artificial Intelligence (AI) to learn, build and store knowledge, enabling accurate predictions about consumer behavior that ultimately provide marketing solutions derived from the large amount of available data.

Through a strategic partnership with Tencent, iClick’s Enterprise Solutions presents strong recurring revenue streams with tremendous opportunities to upsell multi-national corporations (MNCs). Tencent’s proprietary API connection enables brands to build 360-degree consumer profiles based on the collection and integration of purchased behavioral information from online and offline touchpoints, including WeChat Mini Programs, WeChat Payment, WeChat Work and more.

As iClick continues to provide integrated marketing and smart retail solutions targeting Chinese consumers, the company believes Enterprise Solutions has strong long-term growth potential and will become a major gross margin contributor in the future.

Partnerships

In 2019, iClick established various agreements and partnerships with a number of leading southeast and northeast Asian companies for regional diversification and in 2020 is focused on continuing to develop additional partnerships and new business models globally. Many of the world’s top companies are leveraging iClick’s proprietary data platform to precisely identify and reach out to core target audience groups in China.

The company’s partnerships include:

  • A tri-partnership with BTG WELINK, an online retail services arm of Beijing Tourism Group (“BTG”), and Tencent Holdings Ltd., China’s leading provider of internet value added services. As part of this partnership, iClick applies its upgraded solutions to build a private DSP (Demand Side Platform) system for BTG. Using Tencent’s big data advertising platform, iClick can assist BTG to develop precision marketing campaigns.
  • An Advertising Agency Authorization Certificate from Baidu Inc. (NASDAQ: BIDU), under which iClick is designated the authorized agency for native advertising of Baidu’s news feed ads. Native advertising is a consumer-friendly, non-disruptive advertising format that has gained rapid popularity among advertisers in recent years. Native advertising and creative marketing content have become a more effective marketing method among the Chinese young consumers. In 2019, the native advertising sector was estimated to have an around 53.5% share of the online advertising revenue, according to Statista.
  • A joint-venture partnership with VGI Global Media Plc (VGI.BKK), Thailand’s No. 1 online to offline (O2O) solutions provider across advertising, payment and logistics platforms, which enables brands in Southeast Asia to capture the multi-billion-dollar Chinese consumer market through a range of technology-driven marketing solutions.

Case Study: Armani Hotel Dubai

Dubai has been gearing up to welcome the growing wave of Chinese visitors. Chinese nationals are eligible for a 30-day visa-on-arrival into the UAE, which gives Chinese travelers tremendous convenience. In light of this, Armani Hotel Dubai set the objective to increase its sales in this market.

The challenge: What Aarmani Hotel Dubai lacked in executing this goal was insightful understanding of Chinese travelers in particular the demographics that were likely to be attracted to the hotel. Challenged by the huge differences in the business practice, unique culture and language barrier in running digital campaigns in China, Armani Hotel Dubai turned to iClick’s know-how and expertise to guide its campaign to success and meet its sales goal.

The solution: iClick tailored an optimal solution for the hotel to increase brand awareness and booking rate from China – which is the key market for the hotel – and successfully assisted Armani Hotel Dubai in reaching its target Chinese audiences by using China’s most popular mobile and internet sites, including WeChat and Weibo, to improve reach and booking potential.

The results: Due to iClick’s unrivaled technological and execution strengths, Armani Hotel Dubai’s ads were delivered in an omnichannel manner, raising brand awareness and garnering interest between Chinese consumers. Subsequently, Armani Hotel Dubai saw a surge in conversion rate.
During the campaign, the Armani Hotel Dubai brand was connected with 87% of Chinese mobile users.

Award-winning Provider

iClick, a Deloitte Technology Fast50, has received multiple industry awards from the international marketing community. The company is committed to helping clients access digital China with its omni-channel, data-driven marketing solutions that deliver uniquely sharpened marketing capabilities and outstanding advertising results.

Most recently, iClick subsidiary OptAim (Beijing) Information Technology Co., Ltd was recognized by Tencent Ads as a 2019 Gold Service Provider. Tencent Ads also named OptAim the winner of three major annual awards for the second half of 2019: “Outstanding Contribution of the Year,” “Best Technology & Data Application Award,” and “Best Branding Awards.”

In November 2019, company co-founder and CEO Sammy Hsieh was chosen as the winner of the “EY Entrepreneur of The Year China 2019 Award in Technology Category,” an award recognizing his entrepreneurial acumen, innovative spirit and strong leadership. As one of the world’s most prestigious business accolades, the “EY Entrepreneur of The Year” awards program honors those who accomplish success by combining ability with opportunity, and inspire others with great vision, leadership and outstanding achievement.

iClick won the Annual Influential Platform Award and the Innovation Golden Award in Marketing at the Creative Award 2019, as well as the Best Tourism Marketing Agency. The company was also the recipient of the “Best Brand and Performance Marketing Award” at the Performance Marketing Ecosystem Summit 2018 hosted by the Advertising & Marketing Service, a division of Tencent Holdings Limited.

The company in 2018 was also recognized as “Platinum Service Partner of Tencent Social Ads” at the Tencent Key Accounts Mid-Year Summit held in Beijing. The mobile division of iClick, Optaim, received the same award beginning in 2016. Optaim was also the “Best DSP Partner” and “Key Account Data Partner” of Tencent, making it the only player in China with such unique and deep level of cooperation with Tencent Social Ads.

Leadership

Sammy Wing Hong Hsieh, chairman of the board and co-founder, was CEO from 2009 to 2019. Prior to co-founding iClick, Hsieh held senior positions in several prominent technology companies. He was general manager for Asia Pacific at Efficient Frontier (now an Adobe company), a leading digital performance marketing company, and was director of Search Marketing at Yahoo Hong Kong from 2000-2008. Hsieh received a bachelor’s degree in economics from the University of California, Los Angeles.

Jian Tang, director, CEO and co-founder, has 20 years of experience in digital advertising and is well-known in China for his expertise in advertising technologies and big data. In 2012, he founded OptAim, which was acquired by iClick in 2015, and has served key research, engineering and management roles at Yahoo’s global research and development center. Tang received his doctorate in computer engineering from Tsinghua University and was named by Campaign Asia as one of the leaders in its Digital A-List in 2016.

Terence Chi Wai Li, chief financial officer, has 15 years of experience in financial management, investment and business operations. He has served in management roles and advisory capacities at several start-ups, in addition to financial management and fundraising roles. He previously worked at PricewaterhouseCoopers, specializing in M&A due diligence and cross border tax and deal structuring projects. Li received an MBA from Oxford University’s Said Business School. He is a Fellow Member of ACCA, a Member of HKICPA, and a Chartered Financial Analyst.

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK), closed Tuesday's trading session at $10.03, up 4.8067%, on 2,086,760 volume with 8,587 trades. The average volume for the last 3 months is 1,100,250 and the stock's 52-week low/high is $2.79500007/$10.2200002.

Recent News

Cannabis Global Inc. (CBGL)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Global, Inc. (CBGL).

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, has acquired a stake in Natural Plant Extract of California Inc. (“NPE”). The strategic move places CBGL in a prime position in the multibillion-dollar California cannabis space. The agreement, which closed Aug. 31, 2020, outlined Cannabis Global’s acquisition of 18.8% of NPE’s outstanding capital stock for $2 million. To view the full press release, visit http://cnw.fm/cTNMJ. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. The COVID-19 pandemic brought about the closure of many businesses, with industries suffering and economies struggling to recover from the impact of restrictions and lockdowns. When the pandemic began, marijuana was considered an essential business. Now, with millions in lockdown around the world, many are seeking to grow their portfolio by signing up for classes in the Cannabis Training University (“CTU”).

Cannabis Global Inc. (CBGL) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June 2019 and announced its intent to enter the cannabis sector. In August 2020, it changed its corporate identity from MCTC Holdings Inc. to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, CBGL plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

CBGL is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. CBGL believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

CBGL leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, CBGL has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

CBGL has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

CBGL collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market CBGL’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by CBGL. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

CBGL CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

CBGL founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at Cannabis Global.

Cannabis Global, Inc. (CBGL), closed Tuesday's trading session at $0.14, up 16.6667%, on 303,418 volume with 82 trades. The stock's 52-week low/high is $0.05/$3.00.

Recent News

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Exro Technologies Inc. (CSE:XRO)(OTCQB:EXROF) (the "Company" or "Exro") announces that it has granted incentive stock options to certain officers, employees and consultants to purchase an aggregate of 1,692,000 shares in the capital of the Company at a price of $1.00 per share, pursuant to the terms of its stock option plan. All of the options are subject to vesting provisions, and any shares issued upon exercise of an option will be subject to a hold period of four months and one day from the date of grant.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Tuesday's trading session at $0.74, off by 3.8961%, on 305,795 volume with 251 trades. The average volume for the last 3 months is 456,616 and the stock's 52-week low/high is $0.134100005/$1.14999997.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.